Clinical Trials Browser

Observational × tazemetostat × Lymphoid × Clear all

NCT05228158 2026-01-02

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

Active not recruiting

Lymphoma, Follicular